Delivery Order SPE2DE24DA010-SPE2D625F3BDA
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as GALLANT (4569142750), will be performed in Santa Clara, California, and represents a non-set-aside award made through full and open competition. Abbott Vascular specializes in advanced cardiovascular medical...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $39,142.80 by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025. The contract, designated GALLANT (4569455082), carries no set-aside designation, indicating full and open competition. Performance will be completed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $36,320.80 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This delivery order, designated as GALLANT (Contract Number 4569403310), was issued without set-aside provisions, indicating full and open competition. The contract will be performed in Santa Clara, California, with an ultimate completion date of September 15,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $22,780.00 by the Medical Supply Chain division of the Department of Defense. This fixed-price delivery order with economic price adjustment was issued on September 16, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Santa Clara, California. The award was made under full and open competition with no set-aside designation. The delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (No. 4569147994, titled "GALLANT") by the Department of Defense Medical Supply Chain on August 19, 2025, with a ceiling value of $38,345.80. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed in Santa Clara, California. The contract was awarded without set-aside designation, indicating full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3BDADelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $21,425.00 under contract number 4569403311 (GALLANT) by the Defense Logistics Agency's Medical Supply Chain organization. The fixed-price delivery order with economic price adjustment was awarded on September 10, 2025, with an ultimate completion date of September 15, 2025, with performance to take place in Santa Clara, California. This award represents a competitive procurement with no set-aside designation, consistent with Abbott Vascular's typical contracting relationship with the Defense Logistics Agency. This delivery order leverages Abbott Vascular's established capabilities as a critical supplier of advanced cardiovascular medical technologies to the federal government. Abbott Vascular has secured substantial indefinite delivery contracts with the Defense Logistics Agency, including a $117.1 million IDC for comprehensive procedural packages covering cardiovascular devices, instrumentation, and accessories. The company's extensive federal contracting history demonstrates its role as a strategic provider of sophisticated medical devices and support services to federal healthcare systems, making this modest delivery order consistent with its broader portfolio of cardiovascular technology procurement for defense and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 9/10/25 |